The Impact of a "Serious Game" on Improving Patient's Medication Knowledge
NCT ID: NCT01786044
Last Updated: 2017-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
850 participants
INTERVENTIONAL
2014-03-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
NCT05838638
Gamification and Medication Adherence (GAME Adherence)
NCT05326386
Mobile Application and Pregnant Patient Knowledge
NCT03452215
Evaluating Symptom Management Educational Materials for Patients With Prostate Cancer
NCT00769431
The Effects of a Results Management System on Physician Awareness of Post-Discharge Test Results
NCT00146354
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MasterMed
MasterMed, an online interactive educational program
MasterMed
An online interactive educational program
Usual care
Access to an online patient portal
Usual Care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MasterMed
An online interactive educational program
Usual Care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. are age of 18 or older,
3. have at least two medications on their medication list that match our pre-selected medications,
4. have at least three medical conditions on their problem list that match our pre-selected medical conditions,
5. have at least three medications documented on their medication list, and
6. list English as their primary language.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
William Lester
Assistant in Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Lester, MD, MS
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital, Laboratory of Computer Science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital, Internal Medicine Associates
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PCHI MGH 2012-P-002093/1
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
MGH 2012-P-002093/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.